Trial Details

COMPLETED
Basic Information
Clinical ID c533
Identifier NCT06459297
Trial Title Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Crohn's Disease
Interventions -
Participant Information
Sponsor AbbVie
City Chungcheongnam-do
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2024-06-24
Primary Completion Date 2025-12-09
Completion Date 2025-12-09